Dostarlimab 500mg/10ml solution for infusion vials
NHS hospitals in England used £51,749,631 of indicative cost of Dostarlimab 500mg/10ml solution for infusion vials in the 12 months to July 2026, about 0.2% of all hospital medicines spend. That is down 1.2% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Dostarlimab 500mg/10ml solution for infusion vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Dostarlimab 500mg/10ml solution for infusion vials most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Christie Nhs Foundation Trust | £13,211,169 |
| The Clatterbridge Cancer Centre Nhs Ft | £3,043,750 |
| Imperial College Healthcare Nhs Trust | £2,313,721 |
| University College London Foundation Tr | £2,019,354 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,942,819 |
| Guy's & St Thomas' Nhs Foundation Trust | £1,795,636 |
| The Royal Marsden Nhs Foundation Trust | £1,672,002 |
| Derby Teaching Hospitals Nhs Found Trust | £1,212,790 |
| Univ Hpls Bristol Nhs Foundation Trust | £947,860 |
| Maidstone And Tunbridge Wells Nhs Trust | £841,888 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.